The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Methods Of Associating Genetic Variants With A Clinical Outcome In Patients Suffering From Age-Related Macular Degeneration Treated With Anti-Vegf - EP3384049

The patent EP3384049 was granted to Regeneron Pharmaceuticals on Aug 2, 2023. The application was originally filed on Dec 1, 2016 under application number EP16823372A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3384049

REGENERON PHARMACEUTICALS
Application Number
EP16823372A
Filing Date
Dec 1, 2016
Status
Granted And Under Opposition
Jun 30, 2023
Publication Date
Aug 2, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BOULT WADE TENNANTMay 1, 2024BOULT WADE TENNANTADMISSIBLE
POHLMANApr 30, 2024POHLMANADMISSIBLE
WUESTHOFF & WUESTHOFFApr 24, 2024WICHMANNADMISSIBLE
AMGENApr 22, 2024UEXKULL & STOLBERGADMISSIBLE

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTCN104894261
INTERNATIONAL-SEARCH-REPORTWO2012125869
OPPOSITIONUS2007190058
OPPOSITIONUS2012125869
OPPOSITIONUS9254338
OPPOSITIONWO2012125869
OPPOSITIONWO2017096031
SEARCHCN104894261
SEARCHWO2012125869

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents